Practical and robust test for comparing binomial proportions in the randomized phase II setting

Pharmaceutical Statistics ◽

10.1002/pst.2174 ◽

2021 ◽

Author(s):

Kristopher Attwood ◽

Soyun Park ◽

Alan D. Hutson

Keyword(s):

Phase Ii ◽

Robust Test ◽

Binomial Proportions ◽

Randomized Phase Ii

Download Full-text

1400: A Randomized Phase II Trial Evaluating the Importance of Early Erectile Dysfunction Rehabilitation and Unilateral Autologous Sural Nerve Grafting in Patients Undergoing a Unilateral Cavernous Nerve Sparing Radical Prostatectomy for Clinically localized PR

The Journal of Urology ◽

10.1016/s0022-5347(18)31601-x ◽

2007 ◽

Vol 177 (4S) ◽

pp. 461-461 ◽

Author(s):

Christopher G. Wood ◽

David Chang ◽

Run Wang ◽

Yu Shen ◽

Curtis A. Pettaway ◽

...

Keyword(s):

Erectile Dysfunction ◽

Radical Prostatectomy ◽

Phase Ii ◽

Sural Nerve ◽

Phase Ii Trial ◽

Nerve Sparing ◽

Nerve Grafting ◽

Cavernous Nerve ◽

Randomized Phase Ii

Download Full-text

Efficacy, safety and predictive biomarker results from a randomized phase II study comparing atezolizumab vs. docetaxel in patients with advanced NSCLC (POPLAR)

Pneumologie ◽

10.1055/s-0036-1572212 ◽

2016 ◽

Vol 70 (S 01) ◽

Author(s):

A Rittmeyer ◽

A Spira ◽

K Park ◽

J Mazieres ◽

J Vansteenkiste ◽

...

Keyword(s):

Phase Ii ◽

Advanced Nsclc ◽

Phase Ii Study ◽

Predictive Biomarker ◽

Randomized Phase Ii

Download Full-text

RANDOMIZED PHASE II TRIAL OF CARBOPLATIN-PACLITAXEL COMPARED TO CARBOPLATIN-PACLITAXEL-TRASTUZUMAB IN ADVANCED (STAGE III-IV) OR RECURRENT UTERINE SEROUS CARCINOMA: RESULTS OF INTERIM ANALYSIS (NCT01367002)

10.26226/morressier.5770e29bd462b80290b4bae3 ◽

2016 ◽

Author(s):

Alessandro D Santin

Keyword(s):

Phase Ii ◽

Interim Analysis ◽

Phase Ii Trial ◽

Stage Iii ◽

Serous Carcinoma ◽

Advanced Stage ◽

Randomized Phase Ii ◽

Uterine Serous Carcinoma

Download Full-text

Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II Study

Case Medical Research ◽

10.31525/ct1-nct04095208 ◽

2019 ◽

Author(s):

Keyword(s):

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Phase Ii ◽

Phase Ii Study ◽

Proof Of Concept ◽

Randomized Phase Ii ◽

Metastatic Soft Tissue Sarcoma

Download Full-text

Randomized Phase II Study of Bortezomib, Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in Multiple Myeloma.

Case Medical Research ◽

10.31525/ct1-nct04277845 ◽

2020 ◽

Author(s):

Keyword(s):

Multiple Myeloma ◽

Phase Ii ◽

Phase Ii Study ◽

Randomized Phase Ii

Download Full-text

Faculty Opinions recommendation of Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.6028956.6041055 ◽

2010 ◽

Author(s):

Philip Fischer

Keyword(s):

Outer Membrane ◽

Phase Ii ◽

Controlled Trial ◽

Membrane Vesicles ◽

Outer Membrane Vesicles ◽

Randomized Phase Ii

Download Full-text

Faculty Opinions recommendation of A randomized, phase II trial of standard triweekly compared with dose-dense biweekly capecitabine plus oxaliplatin plus bevacizumab as first-line treatment for metastatic colorectal cancer: XELOX-A-DVS (dense versus standard).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717697918.793457734 ◽

2012 ◽

Author(s):

Hans-Joachim Schmoll

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Line Treatment ◽

Randomized Phase Ii ◽

First Line Treatment

Download Full-text

Faculty Opinions recommendation of Randomized phase II study of bortezomib, thalidomide, and dexamethasone with or without cyclophosphamide as induction therapy in previously untreated multiple myeloma.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717962446.793468191 ◽

2012 ◽

Author(s):

Steven Le Gouill ◽

Cyrille Touzeau

Keyword(s):

Multiple Myeloma ◽

Phase Ii ◽

Induction Therapy ◽

Phase Ii Study ◽

Randomized Phase Ii

Download Full-text

Faculty of 1000 evaluation for Automated sedation outperforms manual administration of propofol and remifentanil in critically ill patients with deep sedation: a randomized phase II trial.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.717969496.793472190 ◽

2013 ◽

Author(s):

Andreas Hoeft

Keyword(s):

Critically Ill ◽

Phase Ii ◽

Critically Ill Patients ◽

Phase Ii Trial ◽

Deep Sedation ◽

Randomized Phase Ii

Download Full-text

Faculty Opinions recommendation of FOLFOX4 plus cetuximab administered weekly or every second week in the first-line treatment of patients with KRAS wild-type metastatic colorectal cancer: a randomized phase II CECOG study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717997102.793478384 ◽

2013 ◽

Author(s):

Sabine Tejpar ◽

Loredana Vecchione

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Line Treatment ◽

Wild Type ◽

Randomized Phase Ii ◽

First Line Treatment

Download Full-text